A Meroterpenoid from Tibetan Medicine Induces Lung Cancer Cells Apoptosis through ROS-Mediated Inactivation of the AKT Pathway

As a traditional Tibetan medicine in China, <i>Meconopsis grandis</i> Prain has been used to treat a variety of illnesses by local people for thousands of years. However, the active ingredients contained in <i>Meconopsis grandis</i> Prain and its pharmacodynamic mechanisms ha...

Full description

Bibliographic Details
Main Authors: Yi Huang, Yun Huang, Ge Zhu, Bingzhi Zhang, Yujia Zhu, Bin Chen, Xiaoxia Gao, Jie Yuan
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/4/1939
_version_ 1797619029669576704
author Yi Huang
Yun Huang
Ge Zhu
Bingzhi Zhang
Yujia Zhu
Bin Chen
Xiaoxia Gao
Jie Yuan
author_facet Yi Huang
Yun Huang
Ge Zhu
Bingzhi Zhang
Yujia Zhu
Bin Chen
Xiaoxia Gao
Jie Yuan
author_sort Yi Huang
collection DOAJ
description As a traditional Tibetan medicine in China, <i>Meconopsis grandis</i> Prain has been used to treat a variety of illnesses by local people for thousands of years. However, the active ingredients contained in <i>Meconopsis grandis</i> Prain and its pharmacodynamic mechanisms have scarcely been reported. We isolated a meroterpenoid named D1399 from <i>Meconopsis grandis</i> Prain endophytic fungi with strong antitumor activity. The structure analysis showed that D1399 is an alkaloid containing a 13-membered macrocyclic structure. The IC<sub>50</sub> of D1399 for human lung cancer cells’ viability ranged from 0.88 to 2.45 μM. Furthermore, we utilized TUNEL assay and western blotting to investigate the antitumor effectiveness of D1399. The results have shown that D1399 induced the apoptosis of lung cancer cells on the extrinsic and intrinsic pathways by boosting ROS generation and repressing AKT activity. In the mouse xenograft model, the average tumor weight with 30 mg·kg<sup>−1</sup> D1399 treatment exhibited 73.19% inhibition compared with the untreated control, without affecting body weight loss. Above all, for the first time, our study provides a possible mechanism for the antitumor activity of D1399 in vitro and in vivo as a natural product from Tibetan medicine with <i>Meconopsis grandis</i> Prain, which may be a potentially promising antitumor drug candidate.
first_indexed 2024-03-11T08:21:08Z
format Article
id doaj.art-8d2976d366f844fb86c3e749b924d0ec
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T08:21:08Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-8d2976d366f844fb86c3e749b924d0ec2023-11-16T22:25:18ZengMDPI AGMolecules1420-30492023-02-01284193910.3390/molecules28041939A Meroterpenoid from Tibetan Medicine Induces Lung Cancer Cells Apoptosis through ROS-Mediated Inactivation of the AKT PathwayYi Huang0Yun Huang1Ge Zhu2Bingzhi Zhang3Yujia Zhu4Bin Chen5Xiaoxia Gao6Jie Yuan7Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, ChinaSchool of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, ChinaDepartment of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, ChinaSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, ChinaSchool of Public Health, Sun Yat-sen University, Guangzhou 510080, ChinaSouthern Laboratory of Ocean Science and Engineering, Zhuhai 519000, ChinaSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, ChinaKey Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, ChinaAs a traditional Tibetan medicine in China, <i>Meconopsis grandis</i> Prain has been used to treat a variety of illnesses by local people for thousands of years. However, the active ingredients contained in <i>Meconopsis grandis</i> Prain and its pharmacodynamic mechanisms have scarcely been reported. We isolated a meroterpenoid named D1399 from <i>Meconopsis grandis</i> Prain endophytic fungi with strong antitumor activity. The structure analysis showed that D1399 is an alkaloid containing a 13-membered macrocyclic structure. The IC<sub>50</sub> of D1399 for human lung cancer cells’ viability ranged from 0.88 to 2.45 μM. Furthermore, we utilized TUNEL assay and western blotting to investigate the antitumor effectiveness of D1399. The results have shown that D1399 induced the apoptosis of lung cancer cells on the extrinsic and intrinsic pathways by boosting ROS generation and repressing AKT activity. In the mouse xenograft model, the average tumor weight with 30 mg·kg<sup>−1</sup> D1399 treatment exhibited 73.19% inhibition compared with the untreated control, without affecting body weight loss. Above all, for the first time, our study provides a possible mechanism for the antitumor activity of D1399 in vitro and in vivo as a natural product from Tibetan medicine with <i>Meconopsis grandis</i> Prain, which may be a potentially promising antitumor drug candidate.https://www.mdpi.com/1420-3049/28/4/1939D1399meroterpenoidTibetan medicineapoptosisROSAKT
spellingShingle Yi Huang
Yun Huang
Ge Zhu
Bingzhi Zhang
Yujia Zhu
Bin Chen
Xiaoxia Gao
Jie Yuan
A Meroterpenoid from Tibetan Medicine Induces Lung Cancer Cells Apoptosis through ROS-Mediated Inactivation of the AKT Pathway
Molecules
D1399
meroterpenoid
Tibetan medicine
apoptosis
ROS
AKT
title A Meroterpenoid from Tibetan Medicine Induces Lung Cancer Cells Apoptosis through ROS-Mediated Inactivation of the AKT Pathway
title_full A Meroterpenoid from Tibetan Medicine Induces Lung Cancer Cells Apoptosis through ROS-Mediated Inactivation of the AKT Pathway
title_fullStr A Meroterpenoid from Tibetan Medicine Induces Lung Cancer Cells Apoptosis through ROS-Mediated Inactivation of the AKT Pathway
title_full_unstemmed A Meroterpenoid from Tibetan Medicine Induces Lung Cancer Cells Apoptosis through ROS-Mediated Inactivation of the AKT Pathway
title_short A Meroterpenoid from Tibetan Medicine Induces Lung Cancer Cells Apoptosis through ROS-Mediated Inactivation of the AKT Pathway
title_sort meroterpenoid from tibetan medicine induces lung cancer cells apoptosis through ros mediated inactivation of the akt pathway
topic D1399
meroterpenoid
Tibetan medicine
apoptosis
ROS
AKT
url https://www.mdpi.com/1420-3049/28/4/1939
work_keys_str_mv AT yihuang ameroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT yunhuang ameroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT gezhu ameroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT bingzhizhang ameroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT yujiazhu ameroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT binchen ameroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT xiaoxiagao ameroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT jieyuan ameroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT yihuang meroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT yunhuang meroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT gezhu meroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT bingzhizhang meroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT yujiazhu meroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT binchen meroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT xiaoxiagao meroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway
AT jieyuan meroterpenoidfromtibetanmedicineinduceslungcancercellsapoptosisthroughrosmediatedinactivationoftheaktpathway